KORU Medical Systems, Inc.(KRMD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

KORU Medical Systems, Inc. (KRMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores KRMD at 40.4/100 on a 32-signal composite quality model, placing it at rank #2,106 of 2,962 stocks — the bottom half of the AI-ranked universe. KRMD scores in the top quartile across revenue growth (81.4). Areas of concern include revenue scale (8.0) and balance sheet strength (20.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 21.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), KORU Medical Systems, Inc. reports quarterly revenue of $12.0M, net income of $252.4K, free cash flow of $108.2K. Top institutional holders of KRMD by reported 13-F value include First Light Asset Management, Topline Capital Management, BlackRock, based on the most recent SEC filings. KRMD trades on the Nasdaq exchange and files with the SEC under CIK 704440. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KRMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for KORU Medical Systems, Inc. directly from SEC EDGAR.